![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 11, 2007 4:45:59 PM
I believe there is no way we test $2 before FDA. In fact, earlier today, I was watching $2.52 being defended, as they say, and in my mind, I called it as the down move's low.
You can scoff, as I'm sure you will, but I think the low has been set today (at least pre-FDA) at $2.52. Next week it slowly moves higher from here, IMHO. Once the options expire, there's no other way to play COR.
The bottom line is the science is compelling. The histo findings have been explained. We have waited 14+ months and counting. There is lots of BP interest. The binary event (FDA) is the next major hurdle and the prospects look very good.
As far as management credibility goes. Stoll has only been here a few years. A lot of the past mistakes were with different management. Stoll has pretty much delivered what he has said since he's been around and Cortex's house has never looked better.
If the FDA throws another roadblock up, there will be a big drop and COR will be running on fumes, but it will comeback and that would be the MOABO. But, should the FDA do the right thing and remove any dosing restrictions, COR is probably a 4-bagger from here by years end. These are compelling odds. I only wish I could load up on August options, because I would back the truck up. In another week, the only way to play the upside is by being long the stock.
In a few months, anything sub-$3 will look like a steal, IMHO.
MF4
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM